Vertex Pharmaceuticals Inc / Ma

Performance Wealth Partners, LLC VRTX

Report date

3/31/2026

Quarter

2026 Q1

Filed

4/10/2026

Shares

1,601

Value ($000)

715

Weight

0.0%

2022 Q4 - 2026 Q1 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q1	4/10/2026	715	0.0%	1,601	3/31/2026
2025 Q4	1/21/2026	725	0.0%	1,600	12/31/2025
2025 Q3	11/7/2025	629	0.0%	1,605	9/30/2025
2025 Q2	7/28/2025	712	0.0%	1,600	6/30/2025
2025 Q1	4/22/2025	777	0.0%	1,603	3/31/2025
2024 Q4	1/17/2025	646	0.0%	1,603	12/31/2024
2024 Q3	10/10/2024	752	0.0%	1,616	9/30/2024
2024 Q2	7/22/2024	750	0.0%	1,600	6/30/2024
2024 Q1	4/30/2024	669	0.0%	1,600	3/31/2024
2023 Q4	1/22/2024	651	0.0%	1,600	12/31/2023
2023 Q3	10/30/2023	556	0.0%	1,600	9/30/2023
2023 Q2	7/13/2023	557	0.0%	1,600	6/30/2023
2023 Q1	4/20/2023	378	0.0%	1,200	3/31/2023
2022 Q4	1/19/2023	231	0.0%	800	12/31/2022